BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 30467209)

  • 1. Neurochemical correlates of functional decline in amyotrophic lateral sclerosis.
    Cheong I; Deelchand DK; Eberly LE; Marjańska M; Manousakis G; Guliani G; Walk D; Öz G
    J Neurol Neurosurg Psychiatry; 2019 Mar; 90(3):294-301. PubMed ID: 30467209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultra-High Field Proton MR Spectroscopy in Early-Stage Amyotrophic Lateral Sclerosis.
    Cheong I; Marjańska M; Deelchand DK; Eberly LE; Walk D; Öz G
    Neurochem Res; 2017 Jun; 42(6):1833-1844. PubMed ID: 28367604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultra high-field (7tesla) magnetic resonance spectroscopy in Amyotrophic Lateral Sclerosis.
    Atassi N; Xu M; Triantafyllou C; Keil B; Lawson R; Cernasov P; Ratti E; Long CJ; Paganoni S; Murphy A; Salibi N; Seethamraju R; Rosen B; Ratai EM
    PLoS One; 2017; 12(5):e0177680. PubMed ID: 28498852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor cortex metabolite alterations in amyotrophic lateral sclerosis assessed in vivo using edited and non-edited magnetic resonance spectroscopy.
    Weerasekera A; Peeters R; Sima D; Dresselaers T; Sunaert S; De Vocht J; Claeys K; Van Huffel S; Van Damme P; Himmelreich U
    Brain Res; 2019 Sep; 1718():22-31. PubMed ID: 31002818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive Neurochemical Abnormalities in Cognitive and Motor Subgroups of Amyotrophic Lateral Sclerosis: A Prospective Multicenter Study.
    Ta D; Ishaque A; Srivastava O; Hanstock C; Seres P; Eurich DT; Luk C; Briemberg H; Frayne R; Genge AL; Graham SJ; Korngut L; Zinman L; Kalra S
    Neurology; 2021 Aug; 97(8):e803-e813. PubMed ID: 34426551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An imbalance between excitatory and inhibitory neurotransmitters in amyotrophic lateral sclerosis revealed by use of 3-T proton magnetic resonance spectroscopy.
    Foerster BR; Pomper MG; Callaghan BC; Petrou M; Edden RA; Mohamed MA; Welsh RC; Carlos RC; Barker PB; Feldman EL
    JAMA Neurol; 2013 Aug; 70(8):1009-16. PubMed ID: 23797905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton magnetic resonance spectroscopy in patients with early stages of amyotrophic lateral sclerosis.
    Sivák S; Bittšanský M; Kurča E; Turčanová-Koprušáková M; Grofik M; Nosál' V; Poláček H; Dobrota D
    Neuroradiology; 2010 Dec; 52(12):1079-85. PubMed ID: 20369234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated imaging of [
    Ratai EM; Alshikho MJ; Zürcher NR; Loggia ML; Cebulla CL; Cernasov P; Reynolds B; Fish J; Seth R; Babu S; Paganoni S; Hooker JM; Atassi N
    Neuroimage Clin; 2018; 20():357-364. PubMed ID: 30112276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of diffusion tensor imaging or magnetic resonance spectroscopy in the diagnosis and disability assessment of amyotrophic lateral sclerosis.
    Liu C; Jiang R; Yi X; Zhu W; Bu B
    J Neurol Sci; 2015 Jan; 348(1-2):206-10. PubMed ID: 25524526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between cervical cord 1H-magnetic resonance spectroscopy and clinoco-electromyographic profile in amyotrophic lateral sclerosis.
    Ikeda K; Murata K; Kawase Y; Kawabe K; Kano O; Yoshii Y; Takazawa T; Hirayama T; Iwasaki Y
    Muscle Nerve; 2013 Jan; 47(1):61-7. PubMed ID: 23042532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of the neurochemical profiles in the G93A-SOD1 mouse model of amyotrophic lateral sclerosis.
    Lei H; Dirren E; Poitry-Yamate C; Schneider BL; Gruetter R; Aebischer P
    J Cereb Blood Flow Metab; 2019 Jul; 39(7):1283-1298. PubMed ID: 29400109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What does the ALSFRS-R really measure? A longitudinal and survival analysis of functional dimension subscores in amyotrophic lateral sclerosis.
    Rooney J; Burke T; Vajda A; Heverin M; Hardiman O
    J Neurol Neurosurg Psychiatry; 2017 May; 88(5):381-385. PubMed ID: 27888187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1H-MRS evidence of neurodegeneration and excess glutamate + glutamine in ALS medulla.
    Pioro EP; Majors AW; Mitsumoto H; Nelson DR; Ng TC
    Neurology; 1999 Jul; 53(1):71-9. PubMed ID: 10408539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings.
    Ellis CM; Simmons A; Andrews C; Dawson JM; Williams SC; Leigh PN
    Neurology; 1998 Oct; 51(4):1104-9. PubMed ID: 9781537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the features of proton MR spectroscopy ((1)H-MRS) on amyotrophic lateral sclerosis.
    Han J; Ma L
    J Magn Reson Imaging; 2010 Feb; 31(2):305-8. PubMed ID: 20099342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI.
    Suhy J; Miller RG; Rule R; Schuff N; Licht J; Dronsky V; Gelinas D; Maudsley AA; Weiner MW
    Neurology; 2002 Mar; 58(5):773-9. PubMed ID: 11889242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal thinning of the motor cortex mirrors clinical features of amyotrophic lateral sclerosis and their phenotypes: a neuroimaging study.
    Schuster C; Kasper E; Machts J; Bittner D; Kaufmann J; Benecke R; Teipel S; Vielhaber S; Prudlo J
    J Neurol; 2013 Nov; 260(11):2856-64. PubMed ID: 23996101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ratio of N-acetyl aspartate to glutamate correlates with disease duration of amyotrophic lateral sclerosis.
    Sako W; Abe T; Izumi Y; Harada M; Kaji R
    J Clin Neurosci; 2016 May; 27():110-3. PubMed ID: 26765768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments.
    John NA; Solanky BS; De Angelis F; Parker RA; Weir CJ; Stutters J; Carrasco FP; Schneider T; Doshi A; Calvi A; Williams T; Plantone D; Monteverdi A; MacManus D; Marshall I; Barkhof F; Gandini Wheeler-Kingshott CAM; Chataway J;
    J Magn Reson Imaging; 2024 Jun; 59(6):2192-2201. PubMed ID: 37787109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study.
    Rule RR; Suhy J; Schuff N; Gelinas DF; Miller RG; Weiner MW
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5(3):141-9. PubMed ID: 15512902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.